Autres langues Torrent Pharmaceuticals Limited

Actions

TORNTPHARM

INE685A01028

Produits pharmaceutiques

Temps Différé Bombay S.E. 09:32:21 03/09/2026			Varia. 5j.	Varia. 1 janv.
4 911,05 ^INR	-1,87%		-2,27%	+27,84%

30/07	Transcript : Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026
30/07	Torrent Pharmaceuticals Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI

Autres langues

30/07	Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
30/07	Torrent Pharmaceuticals Limited Announces Management Changes, Effective July 30, 2026
30/07	Torrent Pharmaceuticals Limited Announces Term Completion of Ameera Shah as Independent Director, Effective August 1, 2026
16/07	Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges
09/07	India's Dr Reddy's says semaglutide shipping disruption to last until at least late October
09/07	India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice
09/07	Torrent Pharmaceuticals Limited Implements Voluntary Recall for Select Batches of Semalix Injection Disposable Pens
23/06	Torrent Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended 31 March, 2026
22/05	Torrent Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
22/05	Indian drugmaker Torrent Pharma posts lower quarterly profit on acquisition costs
22/05	Torrent Pharmaceuticals Limited Recommends Final Dividend, Payable on or Around 25 June 2026
06/05	Algorae Pharmaceuticals executes license & supply agreement with Torrent Pharma
10/04	Torrent Pharma says USFDA inspected its Bileshwarpura (oncology) facility from 06-Apr-26 to 10-Apr-26
23/03	Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
21/03	Torrent Pharma says to launch generic oral semaglutide in India
21/03	Torrent Pharmaceuticals Limited Launches Oral and Injectable Formulations of Semaglutide
18/03	Zydus Lifesciences Limited And Torrent Pharmaceuticals Limited Sign Licensing Agreement To Co-Market Semaglutide Injection In India
05/03	Sattrix Bags Work Orders Worth Over INR13 Million for Cyber Security Services
27/02	Xeris Biopharma Sues Torrent Pharmaceuticals, Somerset Therapeutics Over Recorlev Patents
27/02	Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
13/02	Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
13/02	Torrent Pharma Q3 consol net profit 6.35 billion rupees
13/02	Torrent Pharmaceuticals Limited Announces Interim Dividend, Payable on or Around 6 March, 2026
05/02	Merger Of Torrent Pharmaceuticals With JB Chemicals: En Route To Becoming Second-Largest Player In Pharma Industry
05/02	J. B. Chemicals & Pharmaceuticals Limited Announces the Appointment of Kaushal Solanki as the Key Managerial Personnel with Effect from February 5, 2026